BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Staging
2089 results:

  • 1. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
    Ma H; Wu T; Zhang Q; Ding Q
    BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and validation of a nomogram to predict leptomeningeal metastases in lung adenocarcinoma: Cervical lymph node metastasis is an important association factor.
    Hua X; Feng W; Ye M; Lai M; Yu X; Sun M; Li J; Ai R; He Y; Cai L; Shi C; Liu X
    Cancer Med; 2024 May; 13(9):e7206. PubMed ID: 38686619
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical values of different specimen preparation methods for the diagnosis of lung cancer by EBUS-TBNA.
    Wang H; Wang J; Liu Y; Wang Y; Zhou Y; Yu D; You H; Ren T; Tang Y; Wang M
    Diagn Pathol; 2024 Apr; 19(1):61. PubMed ID: 38641621
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Alectinib in Resected
    Wu YL; Dziadziuszko R; Ahn JS; Barlesi F; Nishio M; Lee DH; Lee JS; Zhong W; Horinouchi H; Mao W; Hochmair M; de Marinis F; Migliorino MR; Bondarenko I; Lu S; Wang Q; Ochi Lohmann T; Xu T; Cardona A; Ruf T; Noe J; Solomon BJ;
    N Engl J Med; 2024 Apr; 390(14):1265-1276. PubMed ID: 38598794
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. High risk of lung cancer in surfactant-related gene variant carriers.
    Brudon A; Legendre M; Mageau A; Bermudez J; Bonniaud P; Bouvry D; Cadranel J; Cazes A; Crestani B; Dégot T; Delestrain C; Diesler R; Epaud R; Philippot Q; Théou-Anton N; Kannengiesser C; Ba I; Debray MP; Fanen P; Manali E; Papiris S; Nathan N; Amselem S; Gondouin A; Guillaumot A; Andréjak C; Jouneau S; Beltramo G; Uzunhan Y; Galodé F; Westeel V; Mehdaoui A; Hirschi S; Leroy S; Marchand-Adam S; Nunes H; Picard C; Prévot G; Reynaud-Gaubert M; De Vuyst P; Wemeau L; Defossez G; Zalcman G; Cottin V; Borie R;
    Eur Respir J; 2024 May; 63(5):. PubMed ID: 38575158
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of related factors of CRA in lung cancer patients with different serum iron levels: A retrospective cohort study.
    Li QY; Yang WX; Liu H; Yao JL; Wang Q; Lin D; Shi J
    Cancer Med; 2024 Apr; 13(7):e7147. PubMed ID: 38562035
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The association of visceral pleural invasion with skip N2 metastasis on clinical stage IA NSCLC.
    Minamoto F; Araújo P; D'Ambrosio P; Dela Vega A; Lauricella L; Pêgo-Fernandes P; Terra R
    Clinics (Sao Paulo); 2024; 79():100334. PubMed ID: 38484584
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. lung cancer Diagnoses and Outcomes During the Syrian War, 2011-2018.
    Hanafi I; Abo Samra D; Alsaqqa R; Naeem A; Shebli B; Ajlyakin G
    JAMA Netw Open; 2024 Mar; 7(3):e242091. PubMed ID: 38477917
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Shape-Sensing Robotic-Assisted Bronchoscopy versus Computed Tomography-Guided Transthoracic Biopsy for the Evaluation of Subsolid Pulmonary Nodules.
    Fernandez-Bussy S; Yu Lee-Mateus A; Reisenauer J; Balasubramanian P; Barrios-Ruiz A; Garza-Salas A; Chandra NC; Koratala A; Nadrous A; Edell ES; Bowman AW; Grage RA; Reisenauer CJ; Kurup AN; Patel NM; Chadha R; Hazelett BN; Abia-Trujillo D
    Respiration; 2024; 103(5):280-288. PubMed ID: 38471496
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Exploration and machine learning model development for T2 NSCLC with bronchus infiltration and obstructive pneumonia/atelectasis.
    Jin X; Pan Y; Zhai C; Shen H; You L; Pan H
    Sci Rep; 2024 Feb; 14(1):4793. PubMed ID: 38413705
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Time between imaging and surgery is not a risk factor for upstaging of clinical stage IA non-small-cell lung cancer.
    Barcelos RR; Sugarbaker E; Kennedy KF; McAllister M; Kim S; Herrera-Zamora J; Leo R; Swanson S; Ugalde Figueroa P
    Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38407382
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Factors affecting accuracy of clinical staging in resectable non-small cell lung cancer in a real-world study.
    Gwon HR; La Woo A; Yong SH; Park Y; Kim SY; Kim EY; Jung JY; Kang YA; Park MS; Park SY; Lee SH
    Thorac Cancer; 2024 Mar; 15(9):730-737. PubMed ID: 38380557
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected.
    Cheng J; Zhou L; Wang H
    Front Cell Infect Microbiol; 2024; 14():1296295. PubMed ID: 38371298
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Outcomes Of Surgically Treated N2-Positive Non-Small Cell lung cancer.
    Rei J; Castro P; Guerra M; Miranda J
    Port J Card Thorac Vasc Surg; 2024 Feb; 30(4):23-29. PubMed ID: 38345887
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
    Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
    Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
    Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging.
    Stoevesandt D; Ludwig C; Mauz-Körholz C; Körholz D; Hasenclever D; McCarten K; Flerlage JE; Kurch L; Wohlgemuth WA; Landman-Parker J; Wallace WH; Fosså A; Vordermark D; Karlén J; Cepelová M; Klekawka T; Attarbaschi A; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Daw S; Steglich J
    Pediatr Radiol; 2024 May; 54(5):725-736. PubMed ID: 38296856
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Secondary Analysis of the Rate of Second Primary lung cancer From cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell lung cancer.
    Stinchcombe TE; Wang X; Damman B; Mentlick J; Landreneau R; Wigle D; Jones DR; Conti M; Ashrafi AS; Liberman M; de Perrot M; Mitchell JD; Keenan R; Bauer T; Miller D; Altorki N
    J Clin Oncol; 2024 Apr; 42(10):1110-1113. PubMed ID: 38215351
    [No Abstract]    [Full Text] [Related]  

  • 19. Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell lung cancer: A Nonrandomized Controlled Trial.
    Wu TC; Luterstein E; Neilsen BK; Goldman JW; Garon EB; Lee JM; Felix C; Cao M; Tenn SE; Low DA; Kupelian PA; Steinberg ML; Lee P
    JAMA Oncol; 2024 Mar; 10(3):352-359. PubMed ID: 38206614
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Sublobar resection is associated with less lymph nodes examined and lower delivery of adjuvant therapy in patients with 1.5- to 2.0-cm clinical IA2 non-small-cell lung cancer: a retrospective cohort study.
    Rodriguez-Quintero JH; Kamel MK; Jindani R; Vimolratana M; Chudgar NP; Stiles BM
    Eur J Cardiothorac Surg; 2024 Jan; 65(1):. PubMed ID: 38147358
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 105.